BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33200418)

  • 1. Argyrophilic nucleolar organizing regions in patients with Xeroderma Pigmentosum Group E.
    Karagun E; Eroz R
    Exp Dermatol; 2021 Mar; 30(3):416-417. PubMed ID: 33200418
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple melanoma in xeroderma pigmentosum].
    Fölster-Holst R; Schubert C; Christophers E
    Hautarzt; 1994 Aug; 45(8):554-61. PubMed ID: 7960757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-derived gene-expression profiling in unravelling susceptibility to recessive disease.
    Vahteristo P; Kokko A; Saksela O; Aittomäki K; Aaltonen LA
    J Med Genet; 2007 Nov; 44(11):718-20. PubMed ID: 17660462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral ocular surface squamous neoplasia with bilateral periocular basal cell carcinoma in a case of xeroderma pigmentosum.
    Agarwal R; Chawla B; Asif MI; Pujari A
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29197837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
    Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
    Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal Cell Carcinoma in Cases with or without Xeroderma Pigmentosum.
    Ghartimagar D; Ghosh A; Shrestha SR; Shrestha S; Thapa S; Narasimhan R; Talwar OP
    JNMA J Nepal Med Assoc; 2017; 56(208):432-7. PubMed ID: 29453475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum.
    Kraemer KH; Slor H
    Clin Dermatol; 1985; 3(1):33-69. PubMed ID: 3833325
    [No Abstract]   [Full Text] [Related]  

  • 11. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
    Itoh T
    J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [XERODERMA PIGMENTOSUM WITH BASAL CELL AND SPINOCELLULAR EPITHELIOMA AND MELANOMA].
    GAUMOND E
    Hautarzt; 1964 Aug; 15():448-50. PubMed ID: 14249295
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel mutation identified in the DDB2 gene in patients with xeroderma pigmentosum group-E.
    Karagün E; Eroz R; Gamsızkan M; Baysak S; Eyup Y; Ozcan Y
    Int J Dermatol; 2020 Aug; 59(8):989-996. PubMed ID: 32530099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
    Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
    Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
    Kraemer KH; Lee MM; Andrews AD; Lambert WC
    Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum with multiple malignancies.
    Nalgirkar AR; Borkar SS; Nalgirkar SA
    Indian Pediatr; 2000 Dec; 37(12):1377-9. PubMed ID: 11119344
    [No Abstract]   [Full Text] [Related]  

  • 17. Japanese case of xeroderma pigmentosum complementation group C with a novel mutation.
    Tamesada Y; Nakano E; Tsujimoto M; Masaki T; Yoshida K; Niizeki H; Nishigori C
    J Dermatol; 2018 Apr; 45(4):e80-e81. PubMed ID: 29356054
    [No Abstract]   [Full Text] [Related]  

  • 18. Xeroderma pigmentosum.
    Khanna NN; Thakur V; Pant GC
    Aust N Z J Surg; 1971 Aug; 41(1):50-2. PubMed ID: 5286339
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients.
    Dumaz N; Drougard C; Sarasin A; Daya-Grosjean L
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10529-33. PubMed ID: 8248141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect.
    Kgokolo M; Morice-Picard F; Rezvani HR; Austerlitz F; Cartault F; Sarasin A; Sathekge M; Taieb A; Ged C
    Br J Dermatol; 2019 Nov; 181(5):1070-1072. PubMed ID: 31017654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.